Inhibition Of Plaque Neovascularization Reduces Macrophage Accumulation And Progression Of Advanced Atherosclerosis

This study investigated how new blood vessel growth (called angiogenesis) within arterial plaques affects the progression of atherosclerosis - the buildup of fatty deposits that can lead to heart attacks and strokes. Researchers have long known that atherosclerosis involves chronic inflammation, but this research explored a specific connection between blood vessel formation and immune cell activity within plaques.

Using mice that develop atherosclerosis, the scientists discovered that areas with more new blood vessels also had more inflammatory immune cells called macrophages. They found that these tiny blood vessels, known as vasa vasorum, may act like highways that allow inflammatory cells to enter and accumulate in arterial plaques. When they treated the mice with angiostatin, a natural protein that blocks new blood vessel formation, both the blood vessel growth and macrophage accumulation decreased significantly.

The results suggest that new blood vessels and inflammation create a harmful cycle - blood vessels bring in more inflammatory cells, which then promote even more blood vessel growth. By interrupting this cycle with angiogenesis inhibitors, the researchers were able to slow atherosclerosis progression and reduce plaque inflammation, potentially making plaques more stable and less likely to rupture.

This research provides important insights into how atherosclerosis develops and suggests that targeting blood vessel growth could be a new approach for treating cardiovascular disease. While this was an animal study, understanding these mechanisms may eventually lead to novel therapies that complement current treatments like statins and lifestyle interventions in managing heart disease risk.